politics
The wrong prescription for drug affordability
Why this matters: political developments that affect policy direction and public trust.
The Medication Affordability and Patent Integrity Act would create new regulatory burdens on biotech companies, making it harder and taking longer to develop new treatments, while doing nothing to lower prescription drug prices.
Read full story on The Hill → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop